HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia

Angie N. Pinto, Karen Hawke, Allison Castley, Doris Chibo, Francesca Di Giallonardo, Craig Cooper, Shailendra Sawleshwarkar, Anthony Kelleher, Dominic E. Dwyer

Research output: Contribution to journalArticle

Abstract

Australia has maintained a low prevalence of HIV, with a mainly concentrated epidemic and successful public health response. With the widespread availability of HIV genotyping for resistance testing, and development of phylogenetic methodologies, the field of molecular epidemiology has evolved a deeper understanding of diversity and transmission dynamics of HIV. Studies combining HIV genotype with epidemiological data have allowed insights to be gained into the changing subtype diversity, rates of transmitted drug resistance and transmission networks of HIV in Australia. This review provides an overview of HIV molecular epidemiology studies in Australia.

LanguageEnglish
Pages575-584
Number of pages10
JournalFuture Virology
Volume13
Issue number8
DOIs
Publication statusPublished - 1 Aug 2018

Keywords

  • HIV
  • drug resistance
  • molecular epidemiology
  • phylogenetics
  • subtype diversity
  • transmission networks

ASJC Scopus subject areas

  • Virology

Cite this

Pinto, A. N., Hawke, K., Castley, A., Chibo, D., Giallonardo, F. D., Cooper, C., ... Dwyer, D. E. (2018). HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia. Future Virology, 13(8), 575-584. https://doi.org/10.2217/fvl-2018-0031